Anthony Elias

Anthony Elias

UNVERIFIED PROFILE

Are you Anthony Elias?   Register this Author

Register author
Anthony Elias

Anthony Elias

Publications by authors named "Anthony Elias"

Are you Anthony Elias?   Register this Author

87Publications

2952Reads

12Profile Views

Male breast cancer: a disease distinct from female breast cancer.

Breast Cancer Res Treat 2019 Jan 28;173(1):37-48. Epub 2018 Sep 28.

Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4921-9DOI Listing
January 2019

Targeted Therapies in the Treatment of Sarcomas.

Target Oncol 2018 10;13(5):557-565

Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, 1665 Aurora Court, Anschutz Cancer Pavilion Rm 5310, MS 8111, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-018-0583-0
Publisher Site
http://dx.doi.org/10.1007/s11523-018-0583-0DOI Listing
October 2018

Tissue Inhibitor of Metalloproteinase-3 Promotes Schwann Cell Myelination.

ASN Neuro 2017 Nov-Dec;9(6):1759091417745425

1 Department of Biological Sciences, 169278 Rutgers University , Newark, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1759091417745425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718315PMC
July 2018

NCCN Guidelines Updates: Breast Cancer.

J Natl Compr Canc Netw 2018 05;16(5S):605-610

Presented by Sharon H. Giordano, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, Texas; Anthony D. Elias, MD, University of Colorado Cancer Center, Aurora, Colorado; and William J. Gradishar, MD, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://www.jnccn.org/lookup/doi/10.6004/jnccn.2018.0043
Publisher Site
http://dx.doi.org/10.6004/jnccn.2018.0043DOI Listing
May 2018

Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.

Ann Surg Oncol 2018 Mar 8;25(3):768-775. Epub 2017 Sep 8.

Division of Medical Oncology, University of Colorado Denver School of Medicine - Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-6082-1DOI Listing
March 2018

Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.

Colloids Surf B Biointerfaces 2018 Jan 23;161:200-209. Epub 2017 Oct 23.

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2017.10.060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726926PMC
January 2018

Triple-negative breast cancer in the elderly.

Breast J 2017 11;23(6):627-629

Division of Medical Oncology, University of Colorado Denver School of Medicine, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tbj.12814
Publisher Site
http://dx.doi.org/10.1111/tbj.12814DOI Listing
November 2017

We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas.

Cancer 2017 01 3;123(1):20-24. Epub 2016 Oct 3.

Division of Medical Oncology, Department of Internal Medicine, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215314PMC
January 2017

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

J Clin Oncol 2016 11 30;34(32):3898-3905. Epub 2016 Sep 30.

Christopher W. Ryan, Oregon Health & Science University, Portland, OR; Ofer Merimsky, Sackler School of Medicine, Tel-Aviv, Israel; Mark Agulnik, Northwestern University, Chicago, IL; Jean-Yves Blay, Centre Léon Bérard, Lyon; Antoine Italiano, Institut Bergonié, Bordeaux, France; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Robin L. Jones and Ian R. Judson, The Royal Marsden Hospital, London, United Kingdom; Anthony D. Elias, University of Colorado-Denver, Aurora, CO; Edwin Choy, Massachusetts General Hospital; Jill Y. Buck and Francois Lebel, ZIOPHARM Oncology, Boston, MA; Thierry Alcindor, McGill University Health Center, Montreal, Quebec, Canada; Vicki L. Keedy, Vanderbilt University Medical Center, Nashville, TN; Damon R. Reed, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Robert N. Taub, Columbia University Medical Center; Jonathan J. Lewis, Samus Therapeutics and Molecular Ninja Group; Robert G. Maki, Mount Sinai School of Medicine, New York, NY; Xavier Garcia del Muro, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain; and Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6684DOI Listing
November 2016

Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

Hum Pathol 2016 10 31;56:40-51. Epub 2016 May 31.

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.05.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517318PMC
October 2016

Adaptive Randomization of Neratinib in Early Breast Cancer.

N Engl J Med 2016 Jul;375(1):11-22

From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259558PMC
July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

N Engl J Med 2016 Jul;375(1):23-34

From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259561PMC
July 2016

Anti-androgen therapy in triple-negative breast cancer.

Ther Adv Med Oncol 2016 Jul 31;8(4):305-8. Epub 2016 May 31.

Division of Medical Oncology, University of Colorado School of Medicine, Anschutz Medical Campus, ACP 5310, MS 8117 1665 Aurora Court, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016646735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952024PMC
July 2016

Management of Small T1a/b N0 Breast Cancers.

Authors:
Anthony D Elias

Am Soc Clin Oncol Educ Book 2012 :10-9

From the University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.10DOI Listing
April 2016

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.

Horm Cancer 2015 Dec 23;6(5-6):206-13. Epub 2015 Jul 23.

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora CO, RC1 North P18-5127 Mail Stop 8104, 12800 E. 19th Ave, Aurora, CO, 80015, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-015-0232-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897499PMC
December 2015

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

J Natl Compr Canc Netw 2015 Dec;13(12):1475-85

From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0176DOI Listing
December 2015

Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

J Clin Oncol 2015 Oct 17;33(28):3169-76. Epub 2015 Aug 17.

Cheryl L. Rock, Shirley W. Flatt, Bilgé Pakiz, and Barbara A. Parker, University of California, San Diego, Moores Cancer Center, La Jolla; Patricia A. Ganz, Jonsson Comprehensive Cancer Center and the Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA; Tim E. Byers, Anthony Elias, Rebecca L. Sedjo, and Holly Wyatt, University of Colorado Denver, Aurora, CO; Graham A. Colditz, Jingxia Liu, and Michael Naughton, Washington University School of Medicine, St Louis, MO; Wendy Demark-Wahnefried and Helen Krontiras, University of Alabama Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL; and Kathleen Y. Wolin, Coeus Health, Scale Down, and Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/28/3169.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.1095
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.1095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582146PMC
October 2015

Multiple Hepatic Lesions in a Patient With a History of DCIS.

Oncology (Williston Park) 2015 Sep;29(9):669-70, 678-9

View Article

Download full-text PDF

Source
September 2015

Trabectedin: novel insights in the treatment of advanced sarcoma.

Curr Oncol Rep 2014 Jun;16(6):387

Department of Medicine, University of Colorado at Denver, Denver, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-014-0387-zDOI Listing
June 2014

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.

Breast 2013 Oct 17;22(5):650-6. Epub 2013 Aug 17.

Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.037DOI Listing
October 2013

Metaplastic mammary carcinoma with discrepant hormone receptor results by IHC and RT-PCR.

Oncology (Williston Park) 2013 Jun;27(6):526-7, 566

Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
June 2013

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Breast Cancer Res Treat 2012 Sep 24;135(2):415-32. Epub 2012 Jul 24.

Department of Medicine, Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2164-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818141PMC
September 2012

Contribution of uric acid to cancer risk, recurrence, and mortality.

Clin Transl Med 2012 Aug 15;1(1):16. Epub 2012 Aug 15.

Department of Medicine, Pulmonary Division and Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, V20, Room 3105, Mail stop C-322 12850 East Montview Boulevard, Aurora, CO, 80045-0511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2001-1326-1-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560981PMC
August 2012

What is your diagnosis? Desmoplastic Spitz nevus.

Cutis 2012 Jan;89(1):13, 22

Department of Dermatology, Wilford Hall Medical Center, San Antonio, Texas, USA.

View Article

Download full-text PDF

Source
https://www.mdedge.com/sites/default/files/Document/Septembe
Web Search
January 2012

The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest.

J Clin Oncol 2011 Aug 18;29(24):3205-6. Epub 2011 Jul 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.1303DOI Listing
August 2011

Trabectedin: safety and efficacy in the treatment of advanced sarcoma.

Clin Med Insights Oncol 2011 Mar 16;5:35-43. Epub 2011 Mar 16.

Department of Surgery, GITES Division.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMO.S4907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076042PMC
March 2011

Triple-negative breast cancer: a short review.

Authors:
Anthony D Elias

Am J Clin Oncol 2010 Dec;33(6):637-45

Medical Oncology Department, University of Colorado Health Sciences Center, Aurora, 80045-0508, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3181b8afcfDOI Listing
December 2010

Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.

Oncology (Williston Park) 2009 Aug;23(9):784-91

Division of Medical Oncology, University of Colorado Health Sciences Center, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
August 2009

Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.

Breast Cancer Res Treat 2008 Dec 13;112(3):489-501. Epub 2008 Mar 13.

Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Health Sciences Center at Fitzsimons, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-9923-6DOI Listing
December 2008

A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.

Oncology (Williston Park) 2008 Oct;22(11):1270-6

Department of Medicine, University of Colorado School of Medicine Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
October 2008

A woman with primary breast cancer and a solitary sternal metastasis.

Oncology (Williston Park) 2006 Aug;20(9):1068-71, 1075, 1079-80

Division of Medical Oncology, University of Colorado, Health Sciences Center, USA.

View Article

Download full-text PDF

Source
August 2006

Subacute cutaneous lupus erythematosus associated with leflunomide.

Cutis 2005 Sep;76(3):189-92

Dermatology Clinic, US Army Medical Department Activity, Fort Drum, New York 13602, USA.

View Article

Download full-text PDF

Source
http://lup.sagepub.com/content/17/4/329.full.pdf
Web Search
September 2005

Multistep tumorigenesis and the microenvironment.

Breast Cancer Res 2004 12;6(2):93-101. Epub 2004 Feb 12.

Department of Medicine, Division of Medical Oncology and Colorado Cancer Center, University of Colorado Health Science Center, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
http://breast-cancer-research.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/bcr772DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC400664PMC
July 2005

A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.

Oncology (Williston Park) 2005 Mar;19(3):278, 283-4, 287 passim

Division of Medical Oncology, Denver Health Medical Center, USA.

View Article

Download full-text PDF

Source
March 2005

Autologous stem cell transplantation for small cell lung cancer.

Biol Blood Marrow Transplant 2002 ;8(5):273-80

Statistical Center, Health Policy Institute, Medical College of Wisconsin, Milwaukee 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.pm12064365DOI Listing
July 2003

Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.

Biol Blood Marrow Transplant 2002 ;8(6):326-33

Department of Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
July 2003

Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.

Breast Cancer Res Treat 2003 Feb;77(3):245-52

Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1023/A:1021899904332
Web Search
http://dx.doi.org/10.1023/a:1021899904332DOI Listing
February 2003

Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancer.

Clin Lung Cancer 2002 Sep;4(2):95-103

Division of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/clc.2002.n.019DOI Listing
September 2002